Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine

BACKGROUND: Lung squamous cell carcinoma (LSCC) remains a challenging disease to treat, and further improvements in prognosis are dependent upon the identification of LSCC-specific therapeutic biomarkers and/or targets. We previously found that Syntaxin Binding Protein 4 (STXBP4) plays a crucial rol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Bilguun, Erkhem-Ochir, Kaira, Kyoichi, Kawabata-Iwakawa, Reika, Rokudai, Susumu, Shimizu, Kimihiro, Yokobori, Takehiko, Oyama, Tetsunari, Shirabe, Ken, Nishiyama, Masahiko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526255/
https://ncbi.nlm.nih.gov/pubmed/32993587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07448-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados